AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data. Now, Vyalev (foscarbidopa and ...
IV treatment is one of the most traditionalist and wide-spread treatments provided to the 90% of hospitalised patients, yet, recent supply challenges like the Baxter IV fluids crisis have shown that ...
With the use of some simple calculations it can be demonstrated that the choice of cannula and initial glyceryl trinitrate (GTN) infusion rate for patients with acute left ventricular failure (LVF) ...
Monday: 8:00 a.m. - 4:30 p.m. Tuesday: 8:00 a.m. - 4:30 p.m. Wednesday: 8:00 a.m. - 4:30 p.m. Thursday: 8:00 a.m. - 4:30 p.m. Friday: 8:00 a.m. - 4:30 p.m. Services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results